Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
7.95
+0.06 (0.76%)
At close: Aug 11, 2026, 4:00 PM EDT
7.92
-0.03 (-0.38%)
After-hours: Aug 11, 2026, 7:56 PM EDT
Novavax Employees
Novavax had 749 employees as of December 31, 2025. The number of employees decreased by 203 or -21.32% compared to the previous year.
Employees
749
Change (1Y)
-203
Growth (1Y)
-21.32%
Revenue / Employee
$552,465
Profits / Employee
-$330,748
Market Cap
1.31B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Immatics | 678 |
| MannKind | 592 |
| MeiraGTx Holdings | 409 |
| Monte Rosa Therapeutics | 187 |
| Alpha Tau Medical | 121 |
| Inhibrx Biosciences | 110 |
| Vor Biopharma | 76 |
| Seaport Therapeutics | 58 |
NVAX News
- 5 days ago - Novavax Earnings Call Transcript: Q2 2026 - Transcripts
- 5 days ago - Novavax Quarterly report: Q2 2026 - Filings
- 5 days ago - Novavax Earnings release: Q2 2026 - Filings
- 5 days ago - Novavax Slides: Q2 2026 - Filings
- 5 days ago - Novavax reports Q2 EPS (32c), consensus (38c) - TheFly
- 5 days ago - Novavax raises 2026 adjusted revenue view to $235M-$275M from $230M-$270M - TheFly
- 5 days ago - Novavax lifts annual revenue forecast as licensing bets offset weak vaccine demand - Reuters
- 5 days ago - Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights - PRNewsWire